Paul J. Whiting
UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Mutations in PSEN1 predispose inflammation in an astrocyte model of familial Alzheimer's disease through disrupted regulated intramembrane proteolysis.
Journal: Molecular neurodegeneration
Published: September 26, 2024
The hypermorphic PLCγ2 S707Y variant dysregulates microglial cell function - Insight into PLCγ2 activation in brain health and disease, and opportunities for therapeutic modulation.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: July 04, 2023
A primary rodent triculture model to investigate the role of glia-neuron crosstalk in regulation of neuronal activity.
Journal: Frontiers in aging neuroscience
Published: September 28, 2022
Microglial Expression of the Wnt Signaling Modulator DKK2 Differs between Human Alzheimer's Disease Brains and Mouse Neurodegeneration Models.
Journal: eNeuro
Published: July 25, 2022
Structural Analysis and Development of Notum Fragment Screening Hits.
Journal: ACS chemical neuroscience
Published: June 22, 2022
Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit.
Journal: Journal of medicinal chemistry
Published: May 10, 2022
Alzheimer's Disease Enhanced Tonic Inhibition is Correlated With Upregulated Astrocyte GABA Transporter-3/4 in a Knock-In APP Mouse Model.
Journal: Frontiers in pharmacology
Published: November 25, 2021
Regulation of mitophagy by the NSL complex underlies genetic risk for Parkinson's disease at 16q11.2 and MAPT H1 loci.
Journal: Brain : a journal of neurology
Published: November 12, 2021
Epigenetic repression of Wnt receptors in AD: a role for Sirtuin2-induced H4K16ac deacetylation of Frizzled1 and Frizzled7 promoters.
Journal: Molecular psychiatry
Published: July 05, 2021
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.
Journal: Journal of medicinal chemistry
Published: March 30, 2021
5-Phenyl-1,3,4-oxadiazol-2(3H)-ones Are Potent Inhibitors of Notum Carboxylesterase Activity Identified by the Optimization of a Crystallographic Fragment Screening Hit.
Journal: Journal of medicinal chemistry
Published: October 30, 2020
Last Updated: 09/26/2026